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Abstract
Background—Visuo-spatial disturbances could represent a clinical feature of early stage
Alzheimer’s disease (AD). The magnocellular (M) pathway has anatomo-physiological
characteristic which make it more suitable for detecting form, motion and depth compared with
parvocellular one (P).
Objective—Aim of our study was to evaluate specific visual subsystem involvement in a group
of AD patients, recording isoluminant chromatic and luminance pattern electroretinograms and
pattern visual evoked potentials.
Material and methods—data were obtained from 15 AD patients (9 females and 6 males, mean
age ± 1SD: 77.6 ± 4.01 years) not yet undergoing any treatment, and from 10 age-matched healthy
controls. Diagnosis of probable AD was clinically and neuroradiologically established. PERGs
were recorded monocularly in response to equiluminant red-green (R-G), blue-yellow (B-Y) and
luminance yellow-black (Y-Bk) horizontal square gratings of 0.3 c/deg and 90% contrast, reversed
at 1 Hz. VEPs were recorded in response to full-field (14 deg) equiluminant chromatic R-G, B-Y
and luminance Y-Bk sinusoidal gratings of 2 c/deg, presented in onset (300 ms)–offset (700 ms)
mode, at the contrast levels of 90%.
Results—All data were retrieved in terms of peak-amplitude and latency and assessed using the
Student’s t-test for paired data. Temporal differences of PERGs and VEPs, evoked by Y-Bk
grating in AD patients compared with controls, suggest a specific impairment of the magnocellular
stream.
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Conclusions—Our study support the hypothesis that the impairment of the PERGs and VEPs
arising from the magnocellular streams of visual processing may indicate a primary dysfunction of
the M-pathways in AD.
Keywords
Chromatic stimuli; Pattern electroretinograms; Pattern visual evoked potentials; Magno-; parvo-;
konio-cellular subsystem; Alzheimer’s disease
1. Introduction
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder of elderly characterized
by specific pathological changes resulting in progressive development of cognitive
impairment leading to dementia [40]. A plethora of different theories and hypothesis have
been put forward to explain the pathogenesis and development of the disease. However, the
cause of the sporadic form of the disease is unknown, probably because it is pleiotropic,
caused by ageing in concert with a complex interaction of both genetic and environmental
risk factors [19,26,87].
Histopathological studies have demonstrated that hippocampus and the parahippocampal
regions are the earliest affected regions during AD, suggesting a precise chronological (and
hierarchical) order of involvement: from limbic to associative cortical areas, from
associative to primary sensory cortical areas including the visual cortex. Following this
scheme, the involvement of visual system characterizes a late phase of AD [23,58].
However, recent studies have highlighted an apparent dichotomy between the progress of
histopathological findings in different brain areas and the occurrence of visual dysfunctions
in AD animal model and patients. For example, a recent report has shown that soluble beta-
amyloid affects different types of circuitry in mouse primary visual cortex supporting the
idea that visual system might be functionally impaired even at an early stage of AD [55]. In
addition, clinical studies support a link between cognitive performance and visual
dysfunction even at an early stage of AD. Indeed, the gradual loss of memory and attention
are frequently accompanied by alteration of visuo-spatial function in animal models and AD
patients [31,70]. Undoubtedly, sensory troubles including visual deficits add to and perhaps
exacerbate learning/memory alterations characterizing AD. Among the clinical signs of AD,
visual impairments ranging from visuo-spatial deficits, topographic agnosia, visual agnosia
and Balint’s Syndrome have been described [8,30,45]. In addition, several authors have
reported a reduction of visual acuity in AD [12,37], as well as an abnormal contrast
sensitivity, mainly at lowest frequencies tested [14,61], and colour discrimination deficits,
especially for blue hues [13].
However, visual impairment such as visuo-spatial, colour and motion perception deficits can
be difficult to evaluate in patients with normal routine eye evaluation without the use of
specific psychophysics and electrophysiologic exams [39,44,52,54,73,75,77,86]. Thus, it
turns to be important the issue on how to evaluate subtle and specific deficits affecting
different visual subsystems in AD patients.
The post-receptorial visual pathways of primates contain two major parallel streams specific
for colour contrast/form discrimination and luminance contrast/movement discrimination,
respectively [17,20,38,41,47,68,79,80,82]. The colour-opponent system originates from
small, tonic ganglion cells relaying to parvocellular laminae of the lateral geniculate nucleus
and then projecting to layer 4C-β of the striate cortex. More deeply, recent data showed that
two colour-opponent pathways, red-green (R-G) and blue-yellow (B-Y), form the so-called
parvo- (P) and konio-cellular (K) streams, respectively [16,38,41,43,48,59,60]. The second
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major subsystem, i.e. the achromatic stream, originates from large, phasic ganglion cells
projecting to the magnocellular (M) layers of the lateral geniculate nucleus and then to
laminae 4C-α of the striate visual cortex [16,21,38,41,43,48,59,60]. It is worth to note that
parvocellular cells may also respond well to achromatic contrast stimuli of relatively high-
spatial frequency. However, within the range of spatial frequencies to which both streams
respond, M cells are relatively more sensitive to achromatic contrast and this characteristic
is more prominent at higher temporal frequencies. To date, it is common knowledge that a
specific decline in high-spatial contrast and low-temporal frequency sensitivity suggests a
selective deficit in P-stream [18,35], whereas the loss of motion perception and the
impairment in analyzing low-spatial frequency and contrast luminance are more likely to be
related with severe dysfunction affecting M-pathway [23]. Impairments in motion
perception and target tracing are considered to be a relatively common, however not
selective, symptoms after dementia onset in AD [13]. Specific involvement of the magno-
cellular stream of visual processing is particularly important since cell loss, prevalent
deposition of amyloid plaques and neurofibrillary tangles occur in the primary visual cortex
of AD individuals with a prevalence in the M-pathway [38,39]. Our findings are consistent
with the supposition that AD determines primary sensory disruption. In the past, the reason
for a caution interpretation of previously reported evidences is that there are many
contradictory signs of a specific visual involvement: shrinkage of both P and M ganglion
cells in the retina [23], thinning of the nerve fiber layer [5], as well as pathology in both the
magno- and the parvocellular layers of lateral geniculate nucleus (LGN) [31], without any
definitive conclusion on the selective vulnerability of a visual subsystem.
The present paper proposes the use of electrophysiological exams able to unveil visual
dysfunctions of different visual streams in AD patients. Electrophysiological recordings of
electroretinograms (ERGs) and visual evoked potentials (VEPs) have been already applied
in AD patients. For example in demented patients, the late components (N130, P165, N220)
of the VEPs are often delayed [84,85], even though the waveform shapes do not
substantially change over the adult span [67]. However their relationship with either P- or
M-pathways damage remains uncertain.
Results from several studies have shown that the magnocellular dominated layers 4C-α and
4B and send axonal direct projections to the superficial layers within primary visual cortex
[2,25].
Although recent studies suggest that segregation between main visual streams is not
complete [83], the present paper addresses the hypothesis that AD involves a deficit in the
magnocellular pathway of the visual system using ERGs and VEPs to chromatic (Ch) and
luminance (Lum) stimuli.
Besides that, electrophysiological analysis of these three different streams might be
relatively simple also considering that sensory inputs are conveyed to the LGN, and then to
V1 cortical area, in a one-to-one ordered fashion. Previous reports showed that luminance
and chromatic contrast sensitivity develop independently at different rates, probably
reflecting a different development of postreceptoral neural mechanisms [9,23].
Perhaps, using sinusoidal gratings, there is no need to assess individual visual acuity, neither
to correct any refractory deficit, optical aniseikonia or study AD patients separately in terms
of time of disease onset, educational level, disease duration and presence or predominance
of specific behavioral symptoms. Sinusoidal grating patterns in fact elicit responses that are
minimally or not influenced by small refractive deficit, if not adequately corrected, and
represent the best stimuli for both electrophysiology and spatial contrast sensitivity tests
[10,59].
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We raise the hypothesis that AD involves a deficit in the M-pathway resulting in subtle
dysfunction at the level of retina, post-retinal pathways and/or visual cortex. To this aim we
recorded electroretinograms and visual potentials evoked by chromatic and luminance visual
stimuli (ChPERGs and ChVEPs, Lum ERGs and LumVEPs) in a selected sample of AD
patients and compared results with a control group of age and sex matched healthy subjects.
2. Patients and methods
2.1. Patients and controls
The study was conducted on 15 recently diagnosed patients defined as probable AD,
selected from cases referred to our Neurodegenerative Diseases Centre, nine of them were
females and six males (mean age ± SD: 77.6 ± 4.01 years; range 72–86); they all have been
diagnosed for the first time in the month preceding the inclusion in the study. AD patients
met the diagnostic criteria of probable AD according to the Diagnostic and Statistical
Manual of Mental Disorders, fourth edition (DSM-4), the ICD-10 Classification of Mental
and Behavioral Disorders (ICD-10) and the criteria of the National Institute of Neurologic
and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA [44]). Severity of dementia was assessed using
MMSE [15], even if patients have been examined by means of a extensive standardized
diagnostic protocol [78]; at the time of diagnosis, all the patients. presented a MMSE score
below 23/30. Diagnosis of AD was supported by a exhaustive diagnostic work-up including
morphological and functional neuroimaging. In particular each patient underwent a brain
MRI scan and a FDG-PET semi-quantitative study, electroencephalogram and auditory P300
Event Related Potentials (ERPs). Other possible causes of dementia were excluded. The
disease onset was homogeneous among patients and disease duration from onset varied from
12 to 16 months; no one case showed a cerebrovascular load more than two minor lacunar
microlesions, as proved by neuroimaging. Moreover, we considered as normal small areas of
long T2 MRI-imaging around the frontal horns, reflecting either mild and age-related white
matter changes or minor ischemic events [22,90]. In addition, infarcts and white matter low
attenuation (WMLA) on CT were assumed to be of differential diagnostic value between
vascular and degenerative dementia [34]. Inclusion criteria are summarized in Table 1.
Ten healthy volunteers, five males and five females (age range 69–84 years; mean age ± SD:
75.3 ± 6.2 years), were enrolled as a control group; control group was made of subject ad
hoc selected among people of the department staff and relatives or friends of investigators,
age, sex and education levels were analogous with those of patients; they had never prior
used in other experiments.
All subjects (patients. and controls) underwent a extensive clinical neuro-ophthalmological
examination, including Snellen visual acuity testing (monocular), pupillary function
evaluation, fundoscopic and chromatic vision. No patient had involuntary eye movement or
spontaneous nystagmus, neither ophthalmologic disease, including mild cataract, incipient
macular degeneration, and congenital colour anomaly (Ishihara).
None of the patients was intaking medications, or any psychotropic drugs (sedatives,
neuroleptics or antiepileptics) at the time of inclusion in the study or at least 1 month before
and they all had suspended alcohol consumption at least 48 h before exams. All had a visual
acuity of ≥0.8 Snellen fraction or better (mean visual acuity: 9.0 ± 0.6); the diameter of
undilated pupils was 4–5 mm in both control subjects and patients. We also excluded
patients with suspected psychiatric disorders that might complicate the assessment of
Alzheimer-type dementia and individuals affected by some disability that may prevent the
subject from completing all study requirements (e.g. language difficulties).
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All experiments followed the tenets of the declaration of Helsinki. Both patients and
controls gave their informed consent after the aims and the experimental procedures were
fully explained. The experimental protocol was previously approved by the local ethical
Board of Pisa University Medical School and Neuroscience Department Committee.
2.2. Visual stimuli
Stimuli were designed to preferentially activate functionally separate pathways in the visual
system described as magno-cellular (M), parvo-cellular (P) and konio-cellular (K). Visual
stimuli were equiluminant horizontal sinusoidal gratings, modulated either in luminance (Y-
Bk) and chromaticity (R-G and B-Y). R-G chromatic gratings were obtained by
superimposing (out of phase by 180°) red-black to green-black luminance gratings, and
blue-yellow chromatic grating were obtained by superimposing (also out of phase by 180°)
blue-black to yellow-black luminance gratings. Red-black, green-black, blue-black, and
yellow-black luminance gratings had the same Michelson contrast (K) levels (90%), which
was used to define the contrast of the chromatic grating. Gratings were generated by a VSG/
2 graphic card (Cambridge Research©, UK), displayed full-field on a colour monitor
(Samsung Sync Master1100DF®, 21 inches) at a frame rate of 120 Hz and 14 bits per colour
per pixel, suitably linearized by gamma correction [59,60].
The equiluminant point was detected for each subject by assessing contrast sensitivity with
the method of ascending limits for a 1 c/deg red-green or black-yellow grating [23,60],
counterphased at 15 Hz [50]. The point of minimum sensitivity was taken as the
equiluminant value for the subject. The relative luminance (r) is easily defined by the usual
formula [50]:
where values of r = 0, r = 0.5 (equiluminant point, at maximum chromatic contrast) and r =
1.0 respectively define G-Bk, R-G and R-Bk patterns. Red-green gratings were sinusoidally
reversed at 16 Hz and the r-ratio was varied to null or minimize the perception of flicker.
The extreme values (i.e. r = 0 and r = 1) characterize gratings with pure luminance contrast
and poor chromatic one [60]. This implies that, at low-spatial frequencies below 5 cycles/
deg, contrast sensitivity is greater to the chromatic gratings, consisting of two
monochromatic gratings added in anti-phase, than to either monochromatic grating alone.
Above 5 cycles/deg, contrast sensitivity is greater to monochromatic than to chromatic
gratings. Contrast sensitivity reflects the minimum amount of contrast that an observer needs
to resolve a stimulus of a given size.
It is well known that R-G opponent parvocellular cells respond well to chromatic patterns of
low-spatial frequencies, whereas magnocellular stream respond only weakly at
equiluminance [59,65]: on the other hand, an impairment of Bk-Y grating detection, in terms
of VEPs responses of either poor amplitude or latency, is likely related to involvement of
magnocellular pathway.
In order to minimize distortions produced by short-wavelength cones activation, each
pattern was viewed through yellow filters (Kodak© Wratten 16) that attenuated wavelengths
below 500 nm. Mean luminance was kept at 17 cd m−2, inducing a retinal illuminance of
330 Troland when viewed through undilated natural pupils, estimating to be ~3–5 in both
patients and normal subjects.
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PERGs were recorded monocularly in response to chromatic equiluminant red-green (R-G),
blue-yellow (B-Y) and luminance (Lum) yellow-black (Y-Bk) horizontal sinusoidal gratings
of 0.3 c/deg and 90% contrast (K), reversed at 1 Hz, displayed on a TV monitor at a viewing
distance of 24 cm (59.2 × 59 deg field); PERGs and VEPs were recorded not simultaneously
being the stimuli employed chosen to emphasize retinal or cortical responses: we performed
firstly ChPERGs and then ChVEPs, consecutively on the same session.
VEPs were recorded in response to full-field (14 deg) chromatic equiluminant R-G, B-Y and
luminance Y-Bk sinusoidal gratings of 2 c/deg, presented in onset (300 ms)–offset (700 ms)
mode, at a contrast (K) level of 90%.
2.3. Electrophysiological recordings
a. PERGs: PERGs have been recorded monocularly using common Ag/AgCl
superficial cup electrodes, 9 mm in diameter (electrode impedance < 5 kΩ, inter-
electrode one < 500 Ω), the active taped in mid position over the inferior eyelid, the
reference on the same position of the contralateral patched eye; the ground was
located at the vertex (Cz). PERGs showed a positive–negative waveform (P1–N1)
[65,66]; latencies and amplitudes of different waves were measured using the
cursor with the digital readout on the monitor: amplitudes from peak to baseline for
P1, peak to peak for N1; latencies at P1 and N1 peaks. Sweep duration was 450 ms.
Responses to patterns of zero contrast were frequently recorded to have a measure
of residual noise.
The use of skin electrodes with an inter-ocular recording represents the better
compromise between signal-to-noise ratio and signal stability [56]. Adequate
electrical conduction was achieved by cleansing the skin with alcohol and by
applying an abrasive cream prior to electrode application.
b. VEPs: VEPs were recorded using analogous Ag/AgCl superficial cup electrodes, 9
mm diameter, placed 2 cm above the inion (active) and at the right mastoid
(reference); the vertex was grounded. Electrode resistance was kept below 5 kΩ,
inter-electrode one less than 500 Ω. VEPs were analyzed in terms of mean
amplitude and latency, where the first one corresponded to the voltage difference
between the trough and the subsequent peak of the different waves. Normative data
for the present set of stimuli and recording conditions have been previously
published [60].
2.4. Data post-processing and signal reconstruction
Two traces were obtained for each stimulating pattern to ensure response consistency and
then averaged (see Figs. 1 and 2). The subject under examination was seated in a semi-dark,
acoustically isolated room in front of the display. Prior to the experiment, each subjects was
adapted to the ambient room light for 10 min and were fully corrected according to the
different viewing distances of psychophysical and electrophysiological experiments. Signal
were amplified (ERG 100,000, VEP 50,000 folds), filtered between 0.3 and 100 Hz (6 dB
octave−1), digitised at 1024 Hz with 12 bit resolution and averaged on line by a PC
(Olidata®, Cesena, Italy), using a custom software written in Labview language (Version
7.0, National Instruments, Austin, TX, 1998). Sweeps containing signals higher than 4 V,
corresponding to final display of 80 μV, were automatically rejected to minimize EEG
contamination by eye blinking, ocular movement, or other environmental instrumental-
biological activities. Responses were evaluated separately for partial averages (10- or 20-
sum packets) of the total average (at least 100 sums) to assess consistency. Further details on
recording conditions and normative data used for the present set of stimuli can be found out
elsewhere [60].
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Responses were evaluated separately for partial averages (PERGs, 100 sum or 10 packets,
VEPs 50 sum or 5 packets) of the total average (at least 200 sums) in order to assess
consistency and two or three traces for each eye were superimposed to ensure their
reproducibility.
Transient PERGs were smoothed off-line by running average over 10 points to cancel most
of high-frequency noise coming from eyelid muscle activity, thereby allowing a more
precise evaluation of amplitude and latency results.
The subject under examination was seated in a semi-dark, acoustically isolated room in front
of the display. All had no or small refractive errors, and were fully corrected according to
the different viewing distances of psychophysical and electrophysiological experiments.
Subjects were instructed to fixate a black spot at the centre of the video screen and no
artificial pupils or dilatory agents were used.
2.5. Statistical analysis
All data were analyzed in terms of peak-amplitude and latency (for both PERG and VEPs)
with commercial statistical software (XLSTAT® v. 7.5.2, devised for Windows Excel®,
Microsoft Corporation©, 2002). The obtained values were assessed using the Student’s t-test
for paired data. All the results are reported as mean values ± 2SDs.
All studies parameters were evaluated statistically using a ≤0.05 level of significance,
except when otherwise specified.
3. Results
3.1. Y-Bk (Lum) grating
Transient exemplificative single waveforms and grand average of PERGs and VEPs,
obtained either in controls and AD patients, are summarized in Figs. 1 and 2.
When presented to control subjects (top line), sinusoidal gratings elicited the following
PERG response: P1 mean latency 38.1 ± 2.4 ms, a N1 peak mean latency of 73.4 ± 8.6 ms
and a mean P1 amplitude, evaluated peak to baseline, of 0.3 ± 0.2 and N1 amplitude (peak to
peak) of 1.5 ± 0.90 μV. As regards VEPs, they displayed a characteristic positive–negative–
positive complex, with a main N-wave with an average latency of 166.6 ± 6.8 ms and mean
amplitude of 3.60 ± 1.20 μV.
In AD patients (bottom line), transient PERGs obtained by Y-Bk pattern, had P1 and N1
peak latency with an average of 61.0 ± 5.2 and 96.1 ± 5.8 ms; a mean amplitude of 0.2 ± 0.3
and 0.36 ± 0.59 μV. The VEPs N-wave showed a mean latency of 188.8 ± 8.6 ms and a
mean amplitude of 3.03 ± 0.48 μV (Table 2).
3.2. R-G grating
In control subjects, ChPERG responses consisted mainly of a typical positive–negative (P1–
N1) waveform; time to peak of this positive–negative wave and the amplitude of P1 and the
following negativity were considered as representatives of latency and amplitude. P1
components exhibited a average latency of 65.5 ± 5.7 ms and a mean amplitude, evaluated
peak to baseline, of 0.50 ± 0.3 μV; N1 latency and peak to peak amplitudes values were
respectively 126.9 ± 6.8 ms and 1.16 ± 0.93 μV. The colour VEPs displayed a characteristic
positive–negative–positive waveform: the main N-wave showed a mean latency of 175.1 ±
6.7 ms, and a mean peak to peak amplitude of 2.1 ± 1.94 μV.
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In AD patients, mean latency of R-G P1 and N1 ChPERG components were 62.6 ms ± 7.8
and 131.3 ± 7.8, with a mean amplitude of 0.2 ± 0.14 and 0.47 ± 0.64 μV, respectively. As
far as concerns ChVEPs, latency of N-wave was 176.2 ± 11.1 ms, with a mean amplitude of
2.9 ± 1.78 (Table 2).
3.3. B-Y grating
Average latency of P1 and N1 ChPERG components were in controls respectively 65.0 ±
5.6 and 133.3 ± 5.8 ms; they showed a mean amplitude of 0.1 ± 0.3 and 3.31 ± 1.55 μV,
respectively. As far as concerns ChVEPs, latency of main N-wave was 180.4 ± 8.8 ms, with
mean amplitude of 4.19 ± 1.34 μV.
In AD patients, average latency of P1 and N1 components were respectively 65.0 ± 6.4 ms
and 136.3 ± 9.2; they showed a mean amplitude of 0.26 ± 0.6 and 1.30 ± 0.45 μV,
respectively. ChVEPs latency of N-wave was 179.1 ± 8.7 ms, with a mean amplitude of 3.71
± 1.84 μV.
Moreover, statistical analysis revealed that temporal features and mean amplitudes of
PERGs as well as VEPs to Y-Bk grating in AD patients differ from those in control subjects
(p ≤ 0.01 and p ≤ 0.05, respectively). Also amplitude of R-G and B-Y PERGs resulted light
reduced in AD patients compared with controls.
In addition, to asses retinal versus post-retinal defects, we evaluated the so-called retino-
cortical times (RCT), that is differences between PERG and VEPs, in both groups; we did
not found any significant variation between controls and patients in neither of gratings
presented (Table 3).
4. Discussion
Our data show evident abnormalities both in latency and amplitude of Lum PERGs in AD
patients compared with controls, while no significant differences were found in ChPERGs
between the two groups. VEPs and RCT analysis did not revealed a retinocalcarine pathway
involvement associated with AD, suggesting the existence of a specific magnocellular or M-
pathway deficit.
Previous studies have reported causes an unspecific decline of the response of the visual
system to luminance and colour contrast during ageing but failed to provide a strong
evidence for a selective deterioration of either parvocellular or magnocellular pathways
[23,35]. Since age-dependent modifications were substantially the same for sensitivity to
luminance and colour contrast [63,72], it has been argued that they all arise at a peripheral
level, with obvious reference to senile miosis [23], increased intraocular light scatter,
decreased retinal blood flow in narrow veins [5] or opacification of the ocular media [76],
promoted by regionally specific Aβ proteins aggregation. Some authors have also described
a disease-related enlargement of the optic nerve head cupping as well as a marked thinning
of neuroretinal rim [5]. Others raised the hypothesis that retinal ganglion cell loss, likely as a
consequence of retrograde axonal degeneration, might also be involved in visual deficits
reported in AD [4,53]. However, a combination of these mechanisms is also conceivable
[53].
Another important issue is whether loss of retinal ganglion cells is due to disease-related
amyloidosis or to a primary optic neuropathy [3,35]. More recently, this viewpoint has being
challenged and many studies provides strong evidences that spontaneous generation of
colour is at least partly mediated by the rebound inhibition of adapted wavelength selective
cells in V1 [11,18]. The existence of a wide range of visual variants of AD, characterized by
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different clinical presentation at onset, has been progressively recognized [1,11,31,57]. For
instance, Pietrini et al. [57], using in vivo measures of brain metabolism, described a
distinctive AD patients subgroup characterized by visual symptoms, without any lack in
glucose metabolism within frontal lobe regions, thus with fully preserved memory. These
increasing findings lead us to accurately explore specific visual impairments in AD.
Evidence beyond the retina linked to poor transmission of visual information through
retinocalcarine pathway is not proved by present results as RCT was within normal limits.
Surprisingly, in previous studies individuals who were too confused to perform simple
psychometric tests were able to cooperate enough to have pattern reversal visual evoked
potentials recordings [88,89]. Thus, despite the lack of significant difference between AD
and depressed patients, some authors [39,46] were able to differentiate the two conditions.
The neural activity in the M-pathway is the best candidate to be the high contrast mechanism
detected with pattern reversal and pattern onset/offset VEPs [69]. AD causes a wide and
multi-focal neuronal degeneration affecting visual areas within occipital, temporal and
parietal cortex [62]. Another weighting variable is the non-linear characteristics of the
response generators [59]: most of the magnocellular elements could mainly contribute to the
second harmonic of the PERGs and VEPs, especially when Bk-Y grating is presented.
The involvement of magnocellular stream in AD could be demonstrated by both retinal and
cortico-subcortical evidences. By the way, Sadun et al. [64] observed that while the P-
stream is relatively spared, the largest retinal cells seemed to be selectively affected by
neural degeneration and argued that M-pathway may be involved in some cases of AD. Few
years later, Parisi et al. [56] reported that there was a significant correlation between the
thinning of the neural fiber layer and the ERG responses. On the other hand, Hof et al. [32],
studying AD patients with prominent visual deficits, described a high concentration of
neurofibrillary tangles in area V5 as compared to their occipital fields, likely due to an
extensive M-pathway impairment.
Our findings are consistent with a sparing of foveal retino-cortical pathways and with the
selective impairment of either corticocortical connections between the striate cortex and the
visual associative structures or the temporo-parieto-occipital visual areas, indicating the
different vulnerability of specific pathways during AD progression. In addition our results
are in agreement with Trick et al. [81], that found a significant reduction in the amplitude of
ERG responses possibly driven by the magno-cellular stream of visual processing. From a
cellular point of view, the dorsal visual pathway, commonly named “where” pathway, is
composed mainly of cells of the magnocellular system, whereas the ventral one, defined as
“what” pathway, contains both magnocellular and parvocellular cells [51], even though
histological and in vivo evidences in our species are still lacking. Di Russo and Spinelli [18]
suggested a major involvement of the magnocellular stream in high-order visual processing,
addressing this hypothesis by comparing effects of spatial attention on VEPs recording for
luminance (yellow-black) and chromatic (red-green) stimuli.
Thus, our findings suggest a deficit in primary visual processing and a selective deficit in
secondary visual processing in moderate cases of dementia [9]. The shift is most prominent
for black-yellow gratings. Unfortunately, partial-field stimulation, characterized by an
increased diagnostic yield, did not perform in our study and requires a modified method.
In our relatively small samples, statistical analysis of retino-cortical conduction times, as
well as analysis of P1-wave’s latency and amplitude, did not show any significant difference
between control group and patients: although not yet completely proven, this suggests that
M-stream activation primarily involves extra-geniculate pathways, as firstly reported by
Moore [49] and later described by Jacob et al. [33]. Others [9] reporting P1 differences,
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suggest the possibility of the activation of a particular cluster of magnocellular cells more
sensitive to poor chromatic contrasts and probably related to a selective deficit in secondary
visual processing in moderate cases of dementia. Thus representing a less reliable
electrophysiological marker in AD.
It is worth pointing out that P1 may be prolonged, but more commonly its amplitude is
decreased disproportionately to the change in latency [27,42] and difficult to correlate with
specific lesions occurred within visual central pathways. These differential injuries highlight
novel insights into the pathology of AD; taken together, we provide here a compelling
evidence for the existence of a selective deficit of magnocellular system in AD. However,
the possibility of a selective parvocellular impairment or a widespread visual deficit cannot
be easily ruled out.
For instance, it cannot be excluded that the outer retina may show some signs of impairment
in AD patients: in fact, age-dependent morphological alterations in second-order retinal
neurons is commonly accompanied by dendrites loss, redistribution of glutamate receptors
and simplification of horizontal cells network [71,74]. Blanks and colleagues found that
largest ganglion cells may have been preferentially affected in AD [6,7]. These all processes
are characterized by a clear spatial gradient, increasing in number from the centre to the
periphery of the retina [24,36]. Some authors concluded that the unspecific alterations in
second-order neurons pool reflects an initial age-dependent photoreceptors dysfunctions
[28]. However, it is worth remembering that compensatory remodeling, in relation to
gradual increase in both ectopic synapses and collateral sprouting, follows a similar trend
[74]: it is likely that retinal ganglion cell loss may be partially secondary to retrograde
axonal degeneration [29].
We believe that further studies should be conducted with larger sample sizes to confirm
these results and expanded to include other forms of vision testing; it is desirable that better
understanding of vision-related impairment could guide interventions to improve functional
capacity in patients with dementia.
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Fig. 1.
Transient PERGs in response to either Y-Bk luminance grating (A and D), equiluminant
chromatic R-G (B and E) and B-Y (C and F) in controls (top traces) and AD patients
(bottom traces). For each inset, individual waveform are represented by dotted line, the
grand mean by bold line. Note the amplitude loss for Y-Bk stimuli (A and D) and B-Y (C
and F) stimuli.
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Fig. 2.
Transient VEPs in response to either Y-Bk luminance grating (A and D), R-G (B and E) and
B-Y (C and F) in controls (top traces) and AD patients (bottom traces). As in previous
figure, for each inset, individual waveform are represented by dotted line, the grand mean by
bold line. Note the latency delay for Y-Bk and B-Y stimuli, whereas R-G are relatively
spared.
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Table 1
Criteria followed to diagnose patients before enrollment in the study.
Exam Diagnostic features Key references
Physical findingsa Age > 40 years McKhann et al. [44]
Tierney et al. [75]
MMSEa ≤23/30 McKhann et al. [44]
Tierney et al. [75]
Neuroimaging (CT scan and/or MRI) Cortical thinning; severe hippocampal sclerosis; periventricular leukoaraiosis;
normotensive hydrocephalus
Erkinjuntti et al. [22]
EEG Marked slowing of dominant rhythm; persistence of δ- and θ-waves Albert et al. [1]
a
NINCDS and ADRDA criteria [86].
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D
-a
m
pl
itu
de
 (μ
V
)
0.
2 
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0.
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 ±
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0.
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*
0.
47
 ±
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.6
4
0.
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 ±
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.6
1.
30
 ±
 0
.4
5*
3.
03
 ±
 0
.4
8*
2.
9 
± 
1.
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3.
71
 ±
 1
.8
4
* p
 ≤ 
0.
05
.
**
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≤ 0
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Table 3
Retino-cortical times for Lum (Bk-Y) and Ch (R-G, B-Y) stimuli, both in controls (Cts) and AD patients ±
1SD.
Y-Bk R-G B-Y
Cts 93.2 ± 7.8 48.2 ± 6.8 47.1 ± 7.3
AD 92.7 ± 7.4 44.9 ± 8.7 42.8 ± 7.9
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